SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 347.35 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 1,133.36 |
| Book Value / Share | 4.40 |
| Price / Book | n/a |
| NCAV ($M) | 245.95 |
| NCAV / Share | 0.96 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.07 |
| Return on Assets (ROA) | -0.06 |
| Return on Equity (ROE) | -0.08 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.67 |
| Current Ratio | 5.10 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 461.84 |
| Assets | 1,349.24 |
| Liabilities | 215.89 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 920.45 |
| Operating Income | -33.55 |
| Net Income | -94.80 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 54.91 |
| Cash from Investing | 17.76 |
| Cash from Financing | -49.36 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 207,605 | 1,022,001 | 20.31 | |
| 210,298 | 1,135,766 | 18.52 | |
| 169,333 | 929,626 | 18.22 | |
| 322,383 | 1,445,725 | 22.30 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SLGL – Sol-Gel Technologies Ltd. | SLRX – Salarius Pharmaceuticals, Inc. |
| SLS – SELLAS Life Sciences Group, Inc. | SNGX – Soligenix, Inc. |
| SNPX – Synaptogenix, Inc. |
Financial data and stock pages provided by
Fintel.io